Syndax Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 9.02 M | $197.18 M | 9.27% | 10.14% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 8.05 M | $175.99 M | 0.00% | 9.05% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 5.86 M | $128.13 M | 17.30% | 6.59% |
| STATE STREET CORP | 08/07/2026 | 5.66 M | $123.69 M | 27.73% | 6.36% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 4.05 M | $88.43 M | -4.82% | 4.55% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.93 M | $85.86 M | 2.76% | 4.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 3.78 M | $82.63 M | 0.00% | 4.25% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 2.80 M | $61.17 M | -3.03% | 3.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.58 M | $56.50 M | 19.80% | 2.90% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2026 | 2.56 M | $56.06 M | 8.92% | 2.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 08/14/2026 | 2.50 M | $54.65 M | 0.00% | 2.81% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 2.29 M | $49.98 M | 6.34% | 2.57% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.05 M | $44.90 M | 929.43% | 2.31% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.92 M | $42.01 M | 10.63% | 2.16% |
| UBS GROUP AG | 08/13/2026 | 1.89 M | $41.40 M | 64.15% | 2.13% |
| ELMIND CAPITAL, LP | 08/14/2026 | 1.86 M | $40.55 M | 0.00% | 2.08% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 1.79 M | $39.13 M | 3.33% | 2.01% |
| CANDRIAM S.C.A. | 08/13/2026 | 1.70 M | $37.04 M | 83.29% | 1.91% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 1.63 M | $35.59 M | -5.73% | 1.83% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.58 M | $34.50 M | -0.09% | 1.77% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 1.54 M | $33.71 M | 60.24% | 1.73% |
| NUVEEN, LLC | 08/11/2026 | 1.36 M | $29.83 M | -8.70% | 1.53% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 1.33 M | $29.15 M | -0.54% | 1.50% |
| AISLING CAPITAL MANAGEMENT LP | 08/13/2026 | 1.32 M | $28.79 M | 0.00% | 1.48% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.25 M | $27.34 M | 0.00% | 1.41% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.24 M | $27.11 M | -22.59% | 1.39% |
| CATALIO CAPITAL MANAGEMENT, LP | 08/14/2026 | 1.22 M | $26.58 M | 16.48% | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 1.21 M | $26.55 M | 36.60% | 1.36% |
| PROSIGHT MANAGEMENT, LP | 08/14/2026 | 1.20 M | $26.23 M | 55.84% | 1.35% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 1.11 M | $24.26 M | 58.16% | 1.25% |
| ALGERT GLOBAL LLC | 08/13/2026 | 1.05 M | $22.99 M | 13.24% | 1.18% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 1.04 M | $22.74 M | 3.54% | 1.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 1.01 M | $22.18 M | 40.03% | 1.14% |
| LOOMIS SAYLES & CO L P | 08/14/2026 | 923.62 K | $20.19 M | 100.00% | 1.04% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 877.26 K | $19.18 M | -2.69% | 0.99% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 867.83 K | $18.97 M | -12.43% | 0.98% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 864.99 K | $18.91 M | 0.00% | 0.97% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 853.30 K | $18.65 M | -12.96% | 0.96% |
| NORTHERN TRUST CORP | 08/13/2026 | 845.54 K | $18.48 M | 11.89% | 0.95% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 814.30 K | $17.80 M | 13.86% | 0.92% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 814.30 K | $17.80 M | 100.00% | 0.92% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 633.51 K | $13.85 M | 5.49% | 0.71% |
| MORGAN STANLEY | 08/13/2026 | 588.98 K | $12.88 M | -34.11% | 0.66% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2026 | 560.25 K | $12.25 M | 47.73% | 0.63% |
| APIS CAPITAL ADVISORS, LLC | 08/14/2026 | 556.00 K | $12.15 M | 1.09% | 0.62% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 546.52 K | $11.95 M | 119.13% | 0.61% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 477.18 K | $10.43 M | 1,223.78% | 0.54% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 456.70 K | $9.98 M | 100.00% | 0.51% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 454.10 K | $9.93 M | 130.95% | 0.51% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 446.99 K | $9.77 M | 45.92% | 0.50% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syndax Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 331 institutional investors and hedge funds held shares of Syndax Pharmaceuticals Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 9.02 M
Kynam Capital Management, LP: 8.05 M
GOLDMAN SACHS GROUP INC: 5.86 M
STATE STREET CORP: 5.66 M
BANK OF AMERICA CORP /DE/: 4.05 M
VANGUARD CAPITAL MANAGEMENT LLC: 3.93 M
122.39% of Syndax Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 127.11 M shares in the last 24 months. This purchase volume represents approximately $3.04 B in transactions.